ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105,371,575
Total 13F shares
21,135,686
Share change
-1,196,307
Total reported value
$34,237,327
Put/Call ratio
10%
Price per share
$1.62
Number of holders
50
Value change
-$2,196,851
Number of buys
19
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP N71542109?
CUSIP N71542109 identifies PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2023

As of 30 Jun 2023, ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,135,686 shares. The largest 10 holders included Privium Fund Management B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., EcoR1 Capital, LLC, M28 Capital Management LP, DAFNA Capital Management LLC, Opaleye Management Inc., MACQUARIE GROUP LTD, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP. This page lists 50 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.